Uncategorized

Gaeta’s last role was a brief stint at Shockwave, which named her CFO two months before accepting J&J’s $13.1 billion takeover offer.

Seventeen states sent the letter to Senate leadership this week outlining how Republican’s reconciliation legislation will kick millions off coverage, sicken risk pools and trample on state autonomy.

Only 18% of respondents knew about formal policies at their firms overseeing the use of the technology, while just 20% said staff were required to undergo structured training, according to Wolters Kluwer.

The analysis from the nonpartisan budget scorekeeper found 7.8 million would lose coverage due to Medicaid cuts.

Analysts reacted positively to the news that uniQure is in alignment with the FDA on an accelerated approval pathway and on target for a Q1 2026 submission for its one-time gene therapy for Huntington’s disease—but patients have been here before.

In this episode of Denatured, presented by IQVIA, BioSpace’s head of insights Lori Ellis discusses how AI transformation can help organizations navigate a rapidly evolving regulatory environment with senior director of regulatory innovation and technology, Michelle Gyzen.

A new report from the Lown Institute finds that variability in policies means two nearly identical patients can receive wildly different bills — sometimes within a few blocks of one another.

  En el contexto actual, donde la eficiencia energética y el compromiso medioambiental se han convertido en prioridades globales, apostar por una empresa de energía sostenible como Natural Home constituye un paso firme hacia un modelo de consumo más responsable. Esta com …

The lawsuit alleges that HHS leadership knew the records they used to guide their layoff decisions were inaccurate and contained errors.

The Platform Technology Designation, which precedes the current FDA leadership, is designed to streamline the drug development and review process, particularly for rare diseases.